4.7 Article

BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance

期刊

CANCER DISCOVERY
卷 6, 期 6, 页码 612-629

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-16-0217

关键词

-

类别

资金

  1. R01 grant from the NIH [AG16379]
  2. NIH/NCI Cancer Center [P30 CA008748]
  3. Lindsay and Goldberg Fellowship from the Watson School of Biological Sciences
  4. Spanish Fundacion Ramon Areces
  5. Martin Sass Foundation
  6. Lauri Strauss Leukemia Foundation
  7. EMBO long-term fellowship
  8. NIH/NCI [CA013106]

向作者/读者索取更多资源

Oncogene-induced senescence is a potent barrier to tumorigenesis that limits cellular expansion following certain oncogenic events. Senescent cells display a repressive chromatin configuration thought to stably silence proliferation-promoting genes while simultaneously activating an unusual form of immune surveillance involving a secretory program referred to as the senescence-associated secretory phenotype (SASP). Here, we demonstrate that senescence also involves a global remodeling of the enhancer landscape with recruitment of the chromatin reader BRD4 to newly activated super-enhancers adjacent to key SASP genes. Transcriptional profiling and functional studies indicate that BRD4 is required for the SASP and downstream paracrine signaling. Consequently, BRD4 inhibition disrupts immune cell-mediated targeting and elimination of premalignant senescent cells in vitro and in vivo. Our results identify a critical role for BRD4-bound super-enhancers in senescence immune surveillance and in the proper execution of a tumor-suppressive program. SIGNIFICANCE: This study reveals how cells undergoing oncogene-induced senescence acquire a distinctive enhancer landscape that includes formation of super-enhancers adjacent to immune-modulatory genes required for paracrine immune activation. This process links BRD4 and super-enhancers to a tumor-suppressive immune surveillance program that can be disrupted by small molecule inhibitors of the bromo and extra terminal domain family of proteins. (C) 2016 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据